Tulane University:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Tulane University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9289
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tulane University (Tulane) is an educational service provider that provides biomedical courses and research programs. The university provides educational courses in the fields of architecture, business, law, liberal arts, medicine, public health and tropical medicine, science, engineering, and others. It provides training programs for graduate students, postdoctoral fellows, veterinarians, undergraduates, veterinary students and visiting scientists, among others. Tulane conducts basic and applied biomedical research on human health problems. The university offers research work on developing vaccines, and treatments and diagnostic tools for infectious diseases such as Lyme disease, malaria, AIDS, tuberculosis, and others. Tulane is headquartered in New Orleans, Louisiana, the US.

Tulane University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tulane University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tulane University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tulane University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tulane University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tulane University, Medical Devices Deals, 2012 to YTD 2018 9
Tulane University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Tulane University, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Cyclica Enters into Agreement with Tulane University 11
Licensing Agreements 12
Andarix Pharma Enters into Licensing Agreement with Tulane University 12
AxoSim Technologies Enters into Licensing Agreement with Tulane University 13
Asset Transactions 14
SanBio Acquires Patent Portfolio Regarding Cell Medicines from Tulane University 14
Tulane University – Key Competitors 15
Tulane University – Key Employees 16
Tulane University – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 19
Government and Public Interest 19
May 18, 2018: Stroke Researchers Confirm Role of Frontal Lesions in Response to Prism TreatmentHomeStroke 19
Product News 20
07/11/2017: Tulane University awarded $12 million to create Lassa vaccine and treatment 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Tulane University, Pharmaceuticals & Healthcare, Key Facts 2
Tulane University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tulane University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tulane University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tulane University, Deals By Therapy Area, 2012 to YTD 2018 8
Tulane University, Medical Devices Deals, 2012 to YTD 2018 9
Tulane University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cyclica Enters into Agreement with Tulane University 11
Andarix Pharma Enters into Licensing Agreement with Tulane University 12
AxoSim Technologies Enters into Licensing Agreement with Tulane University 13
SanBio Acquires Patent Portfolio Regarding Cell Medicines from Tulane University 14
Tulane University, Key Competitors 15
Tulane University, Key Employees 16
Tulane University, Subsidiaries 17

List of Figures
Tulane University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tulane University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tulane University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tulane University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tulane University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Tulane University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tulane University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tulane University, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Tulane University:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NEC Capital Solutions Ltd. (8793):企業の財務・戦略的SWOT分析
    NEC Capital Solutions Ltd. (8793) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Cegedim SA (CGM):企業の財務・戦略的SWOT分析
    Summary Cegedim SA (Cegedim) is a technology company that offers healthcare technical services. The company offers solutions to facilitate business and medical operations. It offers health and preventive health management software used in management of individual and collective health and preventive …
  • Lazard Ltd:企業の戦略・SWOT・財務分析
    Lazard Ltd - Strategy, SWOT and Corporate Finance Report Summary Lazard Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Bachmann electronic GmbH:企業の戦略的SWOT分析
    Bachmann electronic GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Arkansas Children’s Hospital:企業の戦略的SWOT分析
    Arkansas Children's Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Meritage Midstream Services II LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Meritage Midstream Services II LLC (Meritage Midstream), a subsidiary of Howard Midstream Energy Partners LLC, is an oil and gas company that provides midstream services. The company offers natural gas gathering, compression and handling, NGL treating and processing; natural-gas liquids trea …
  • Carl Zeiss Meditec AG (AFX)-医療機器分野:企業M&A・提携分析
    Summary Carl Zeiss Meditec AG (Carl Zeiss Meditec), a division of Carl Zeiss AG, an integrated medical technology company which operates in the fields of ophthalmology, neuro/ENT surgery and surgical ophthalmology. It provides comprehensive packages of solutions for the diagnosis and treatment of ey …
  • Aecon Group Inc (ARE):企業の財務・戦略的SWOT分析
    Aecon Group Inc (ARE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Bajaj Corp Limited
    Bajaj Corp Limited - Strategy, SWOT and Corporate Finance Report Summary Bajaj Corp Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Visteon Corp (VC):企業の財務・戦略的SWOT分析
    Visteon Corp (VC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Pernod Ricard SA (RI):企業の財務・戦略的SWOT分析
    Pernod Ricard SA (RI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Provepharm life Solutions SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Provepharm life Solutions SA (Provepharm) is a life sciences research and pharmaceutical company which focuses on innovative specialty care products for hospitals. The company’s product portfolio includes; methylthioninium chloride proveblue, provayblue methylene blue, proveblue methylene bl …
  • Mitsubishi Research Institute Inc (3636):企業の財務・戦略的SWOT分析
    Mitsubishi Research Institute Inc (3636) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Astra Microwave Products Limited:企業の戦略・SWOT・財務分析
    Astra Microwave Products Limited - Strategy, SWOT and Corporate Finance Report Summary Astra Microwave Products Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Fubon Bank (Hong Kong) Ltd:企業の戦略的SWOT分析
    Fubon Bank (Hong Kong) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Pinnacle Entertainment Inc:戦略・SWOT・企業財務分析
    Pinnacle Entertainment Inc - Strategy, SWOT and Corporate Finance Report Summary Pinnacle Entertainment Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Gulfport Energy Corp (GPOR):企業の財務・戦略的SWOT分析
    Gulfport Energy Corp (GPOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Ship Finance International Ltd (SFL):石油・ガス:M&Aディール及び事業提携情報
    Summary Ship Finance International Ltd (Ship Finance International) is a provider of bulker, tanker, container, and offshore solutions. The company offers fleet of vessels such as crude oil tankers for ultra-deep water semi-submersible dry bulk carriers and drilling rigs, among others. It also opera …
  • The Landis Taipei Hotel Co., Ltd:企業の戦略・SWOT・財務情報
    The Landis Taipei Hotel Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary The Landis Taipei Hotel Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Viking Line ABP:企業の戦略・SWOT・財務情報
    Viking Line ABP - Strategy, SWOT and Corporate Finance Report Summary Viking Line ABP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆